← Open Payments lookup

JOANNE BLAIR-RANDOLPH: Open Payments

NPI 1144351123 · LYNWOOD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,689 in 113 payments from 9 companies in 2025. Trend: 2023 $1,873 · 2024 $2,356 · 2025 $2,689

Food & beverage: $2,677Education: $12
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.26$618
Janssen Pharmaceuticals, Inc18$509
E.R. Squibb & Sons, L.L.C.14$461
Neurocrine BioSciences, Inc.10$315
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)17$236
Teva Pharmaceuticals USA, Inc.12$234
Alkermes, Inc.11$210
ABBVIE INC.3$66
Axsome Therapeutics, Inc.2$41

Products named: INVEGA SUSTENNA, COBENFY, ABILIFY ASIMTUFII, INGREZZA, CAPLYTA, ARISTADA, UZEDY, ABILIFY MAINTENA.

Industry payments across CA — which companies pay providers there.